Primary Site >> Liver Cancer

Gene >> GOLGA6A

Journal: Toxicology. 2014 May 7;319:23-37.
Title: Responses of the steroidogenic pathway from exposure to methyl-tert-butyl ether and tert-butanol.
Author: de Peyster, Ann|Mihaich, Ellen|Kim, Do Hyung|Elyea, William A|Nemec, Matthew J|Hirakawa, Brad P|Leggieri, Shannon E
PMID: 24560773
Journal: Hepat Mon. 2015 Jul 23;15(7):e30336.
Title: Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver.
Author: Geramizadeh, Bita|Seirfar, Nasibe
PMID: 26300935
Journal: Dan Med J. 2017 May;64(5).
Title: The role of incretin hormones and glucagon in patients with liver disease.
Author: Junker, Anders Ellekaer
PMID: 28552096
Journal: J Investig Med. 2018 Jan;66(1):7-10.
Title: Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option.
Author: Dhir, Gauri|Cusi, Kenneth
PMID: 28918389
Journal: Neuropharmacology. 2018 Mar 15;131:282-290.
Title: Brainstem GLP-1 signalling contributes to cancer anorexia-cachexia syndrome in the rat.
Author: Borner, Tito|Liberini, Claudia G|Lutz, Thomas A|Riediger, Thomas
PMID: 29247677